[REGN] YoY Quarter Result on 31-Dec-2024 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-Feb-2025
Financial Year
2024
Quarter
31-Dec-2024 [#Q4]
Profit Trend
QoQ- -31.55%
YoY- -20.86%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 3,789,200 3,434,300 3,414,400 4,951,700 2,422,900 2,169,500 1,927,800 11.91%
PBT 958,100 1,147,600 1,324,700 2,503,400 1,224,600 889,800 676,200 5.97%
Tax 40,400 -12,000 127,600 274,400 75,400 97,800 -144,200 -
NP 917,700 1,159,600 1,197,100 2,229,000 1,149,200 792,000 820,400 1.88%
Tax Rate -4.22% 1.05% -9.63% -10.96% -6.16% -10.99% 21.33% -
Total Cost 2,871,500 2,274,700 2,217,300 2,722,700 1,273,700 1,377,500 1,107,400 17.19%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin 24.22 33.77 35.06 45.01 47.43 36.51 42.56 -8.95%
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS 8.53 10.88 11.19 20.99 10.90 7.25 7.58 1.98%
EPS Diluted 8.06 10.19 10.50 19.69 10.24 6.93 7.15 2.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.